{"slideshow_credits": null, "snippet": "Employees at the German drug maker wondered how the bottom line might be affected by safety tests for patients taking the antistroke drug.", "abstract": null, "section_name": "Business Day", "print_page": "", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/02/08/business/new-emails-in-pradaxa-case-show-concern-over-profit.html", "lead_paragraph": "Employees at the German drug maker wondered how the bottom line might be affected by safety tests for patients taking the antistroke drug.", "headline": {"main": "New Emails in Pradaxa Case Show Concern Over Profit", "print_headline": "New Emails in Pradaxa Case Show Concern Over Profit"}, "_id": "52f5662e38f0d823a37dd6a8", "word_count": "798", "multimedia": [], "pub_date": "2014-02-08T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Pradaxa (Drug)", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Tests (Medical)", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Boehringer Ingelheim GmbH", "name": "organizations", "is_major": "N", "rank": "2"}, {"value": "Stroke", "name": "subject", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}